Personalising the decision for prolonged dual antiplatelet therapy: development, validation and potential impact of prognostic models for cardiovascular events and bleeding in myocardial infarction survivors

HIGHLIGHTS

• who: Prognosis and collaborators from the The Farr Institute of Health Informatics Research, University College London, London, UK have published the article: Personalising the decision for prolonged dual antiplatelet therapy: development, validation and potential impact of prognostic models for cardiovascular events and bleeding in myocardial infarction survivors, in the Journal: (JOURNAL) of 10/01/2017
• what: The authors evaluated prescriptions indicating prolonged clopidogrel use in follow up (defined in Supplementary material online, Table S2) in the cohort to ensure they were untreated with long-term DAPT i.e. the decision the models aimed to aid . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.